4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-22-001318
Director sold 4,500 shares at an average $64.71 ($291,192)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PERRY MICHAEL S Director | 2022-01-03 | Sale | −2,628 | $64.30 | $168,980 | 87,372 | D: show line 1 in the form |
| PERRY MICHAEL S Director | 2022-01-03 | Sale | −1,600 | $65.12 | $104,192 | 85,772 | D: show line 2 in the form |
| PERRY MICHAEL S Director | 2022-01-03 | Sale | −272 | $66.25 | $18,020 | 85,500 | D: show line 3 in the form |
| Open-market sales · 4,500 sh · avg $64.71 · $291,192 | |||||||
Loading xslF345X03/doc4.xml…